CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE IN REMISSION

Clinical trials for CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE IN REMISSION explained in plain language.

Never miss a new study

Get alerted when new CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE IN REMISSION trials appear

Sign up with your email to follow new studies for CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE IN REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New transplant combo aims to tame Graft-Versus-Host disease

Disease control Ongoing

This study tests a stem cell transplant method for people with blood cancers like leukemia or lymphoma. The approach combines chemotherapy and radiation before transplant with a drug called cyclophosphamide after transplant to lower the risk of graft-versus-host disease, where do…

Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE IN REMISSION

Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control

Last updated May 01, 2026 15:58 UTC

CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE IN REMISSION

Get alerted when new CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE IN REMISSION trials appear

New transplant combo aims to tame Graft-Versus-Host disease